Cardiology News

PRINCETON, N.J.--(BUSINESS WIRE)--U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications...

CHICAGO--(BUSINESS WIRE)--A new independent study by researchers at Aon has found significant cost reductions for employers offering Hello Heart's digital heart health program....

PONTE VEDRA, Fla.--(BUSINESS WIRE)--Cadrenal Therapeutics to present at inaugural Centri Capital Conference at Nasdaq on April 22, 2025....

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that it has received Breakthrough Device designation from the U.S. Food and Drug Administration (“FDA”) for its vCLASTM Cryoablation System for the treatment of drug-refractory, recurrent, sustained monomorphic ventricular tachycardia (“VT”) in patients with ischemic or non...

PARIS--(BUSINESS WIRE)--Artedrone, Truffle Capital’s medtech portfolio company developing an autonomous microrobotic solution for mechanical thrombectomy (MT) procedures to treat patients suffering from a stroke, announced the successful completion of a set of various in vitro and animal studies demonstrating the ability of the company’s SASHA microrobotic solution to autonomously perform mechanical thrombectomy. Results from the study are being submitted for publication in to a research journa...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--CardioFocus Announces Successful Clinical Cases with QuickShot™ Nav Large Area Focal PFA Catheter...

TAMPA, Fla.--(BUSINESS WIRE)--Managing high blood pressure just got easier for the millions of Americans struggling to stay on track. Smart Meter, a leader in remote patient monitoring (RPM) solutions, has partnered with Kura Care, a pioneer in AI-driven patient engagement, to launch an integrated, personalized blood pressure program designed to empower patients and enhance care team support. This powerful new collaboration combines Smart Meter’s innovative, cellular-connected iBloodPressure so...

BARCELONA, Spain & MARIN, Calif.--(BUSINESS WIRE)--Anaconda Biomed, S.L. has announced that results of the ANAIS Study, which evaluated the safety and performance of its ANA funnel catheter in the endovascular treatment of large vessel occlusion acute ischemic stroke, have been published in the American Journal of Neuroradiology. The data demonstrated high rates of reperfusion and first-pass success with a strong safety profile, supporting the ANA device as an adjunct to stent retriever thrombe...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2025 after the market closes on Wednesday April 23, 2025, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “Investor Relations” section of the Edwards website at ir.edwards.com. About Edwards L...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its first quarter 2025 financial results before the market opens on Wednesday, April 30, 2025. A press release detailing the quarterly results will be issued that day at approximately 6:30 a.m. Eastern Time. United Therapeutics will host a public webcast Wednesday, April 30, 2025, at 9:00 a.m. Eastern Time. The webcast will be accessible via Unit...